Clinical trial data published in the New England Journal of Medicine and reporting from testing teams at UCL and Moorfields show the PRIMA wireless retinal implant can restore reading vision and enable tasks like crossword puzzles for some patients with advanced macular degeneration. Results described notable functional gains in patients using a camera‑linked glasses system paired with the subretinal chip. Separately, Science Corporation acquired Pixium Vision’s PRIMA program assets for about €4 million after Pixium faced bankruptcy, giving Science immediate access to a device near market readiness. Science is pursuing regulatory talks in Europe and the U.S.; investigators emphasized the magnitude of effect in some patients as unprecedented for electronic retinal implants.